Mar-Acarbose · DIN 02494086 · 100 mg · tablet
Limited Use, Reason for Use code 175, 176 requiredMarketed · checked November 17, 2026
StatusLimited Use, Reason for Use code 175, 176 required
Write on scriptone applicable Reason for Use code, 175 or 176 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 175, 176
Coverage limit:
For the treatment of non-insulin-dependent diabetes mellitus (NIDDM):
Reason for Use code 175
In patients who cannot tolerate or have failed treatment with other oral hypoglycemic agents or in whom other oral hypoglycemic agents are contraindicated;
Coverage limit:
LU Authorization Period: Indefinite
Reason for Use code 176
In patients who require combination therapy with more than one oral hypoglycemic agent to control their serum glucose concentrations.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Mar-Acarbose · DIN 02494086
Manufacturer: Marcan Pharmaceuticals Inc.; listing date 2020-03-31
Health Canada: Marketed since 2020-02-05 · brand MAR-ACARBOSE · ATC A10BF01 ACARBOSE · form Tablet · route Oral · ingredients ACARBOSE 100 MG · company Marcan pharmaceuticals inc · schedule Prescription
Mar-Acarbose: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2053). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02494086)
Source record
DIN 02494086: Mar-Acarbose
Raw flags: chronicUseMed=Y, insOH=Y, sec12=Y, sec3=Y
Item: 682002012; group id 739; item number 1808; lccId 00113; manufacturer id MAR
Source form: Tab; strength: 100mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit); diabetes medication flag
Source prices (unrounded): $0.2053; ministry $0.2053
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02494086
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98411
Interchangeable products
Glucobay · DIN 02190893 · not recorded
Shortage status: not checked (no credentials)